AC Immune SA
ACIU
$2.20
$0.052.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.06% | -3.61% | -235.75% | 137.11% | -34.41% |
| Total Depreciation and Amortization | 24.62% | 7.06% | -3.89% | -1.61% | 0.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.38% | 746.45% | -144.58% | -243.74% | 432.74% |
| Change in Net Operating Assets | -96.83% | -112.33% | 254.20% | -4,257.27% | 18,413.93% |
| Cash from Operations | -123.41% | -1,887.09% | 136.95% | -8.59% | 614.26% |
| Capital Expenditure | -501.33% | -41.40% | 45.33% | 38.36% | 56.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 135.08% | 114.14% | -116.07% | -139.17% | -1,405.96% |
| Cash from Investing | 134.53% | 112.50% | -116.57% | -145.15% | -1,361.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.40% | -51.50% | -23.02% | -23.74% | -28.15% |
| Issuance of Common Stock | -97.78% | -- | -- | -- | -93.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 120.83% | 99.04% | -- | -100.00% | -242.86% |
| Cash from Financing | -336.44% | 63.53% | -100.48% | -139.43% | -103.22% |
| Foreign Exchange rate Adjustments | 3.82% | -115.03% | 226.66% | -5,486.25% | -3,531.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 216.01% | 26.15% | -91.65% | -141.97% | 68.94% |